By Product
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2011/FY
2010/FY
2009/FY
Stock NameRevenueRatio
Late clinical and commercial business2.31B67.60%
Early clinical business779.95M22.81%
新兴业务304.96M8.92%
Other22.98M0.67%
By Industry
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2011/FY
2010/FY
2009/FY
Stock NameRevenueRatio
小分子原料药业务3.09B90.41%
新兴业务304.96M8.92%
Other business22.98M0.67%
By Country/Region
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2011/FY
2010/FY
2009/FY
Stock NameRevenueRatio
Abroad2.33B68.23%
China1.09B31.77%
